Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	inclusion criteria: 1. subjects who have obtained written consent voluntarily to participate in this clinical trial 2. subjects whose age at the time of obtaining consent is 18 years or older 3. subjects who are negative for sars-cov-2 by pcr test 4. subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test	inclusion criteria: 1. subjects who have obtained written consent voluntarily to participate in this clinical trial 2. subjects whose age at the time of obtaining consent is 18 years or older 3. subjects who are negative for sars-cov-2 by pcr test 4. subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test
July 1, 2022, 11 p.m.	usa	inclusion criteria: subjects who have obtained written consent voluntarily to participate in this clinical trial subjects whose age at the time of obtaining consent is 18 years or older subjects who are negative for sars-cov-2 by pcr test subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test	inclusion criteria: subjects who have obtained written consent voluntarily to participate in this clinical trial subjects whose age at the time of obtaining consent is 18 years or older subjects who are negative for sars-cov-2 by pcr test subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test
June 9, 2022, 4 p.m.	usa	None	None
Nov. 16, 2021, 6:30 p.m.	usa	inclusion criteria: subjects who have obtained written consent voluntarily to participate in this clinical trial subjects whose age at the time of obtaining consent is 18 years or older subjects who are negative for sars-cov-2 by pcr test subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test	inclusion criteria: subjects who have obtained written consent voluntarily to participate in this clinical trial subjects whose age at the time of obtaining consent is 18 years or older subjects who are negative for sars-cov-2 by pcr test subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test
Dec. 9, 2020, 12:31 a.m.	usa	inclusion criteria: 1. subjects who have obtained written consent voluntarily to participate in this clinical trial 2. subjects whose age at the time of obtaining consent is 18 years or older 3. subjects who are negative for sars-cov-2 by pcr test 4. subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test	inclusion criteria: 1. subjects who have obtained written consent voluntarily to participate in this clinical trial 2. subjects whose age at the time of obtaining consent is 18 years or older 3. subjects who are negative for sars-cov-2 by pcr test 4. subjects who are negative for both sars-cov-2 igm antibody and sars-cov-2 igg antibody by antibody test